Franziska C Trudzinski

Pulmonology — University Hospital Heidelberg, Germany

LeadR Profile

Franziska C Trudzinski University Hospital Heidelberg Germany
811 ScienceLeadR Reputation 811
Network Map

Pulmonology

Subspecialties: Public Health - Nutrition - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026

Source: PubMed

Heidelberg University (Germany)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 271

Citations

Citations: 1 474 1st author: 46 Last author: 59 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Safety and diagnostic yield of transbronchial lung cryobiopsy in patients with interstitial lung disease and severe pulmonary function impairment.
lung, safety, biopsy, lung diseases, vital capacity, lung diseases, interstitial
Respir Res20260
Safety and pharmacokinetics of inhaled aloxistatin: A first-in-human phase 1 dose escalation trial.
laboratories, safety, pharmaceutical preparations, inhalation, drug-related side effects and adverse reactions, pharmacology, therapeutics, pharmacokinetics
Br J Clin Pharmacol20260
A specialist-led interprofessional weaning program to prevent weaning failure in high-risk patients: the PRiVENT study.
ventilation, weaning
Crit Care20260
Out-of-Hospital Intensive Care in Germany - who´s out there? Key issues revealed by the clinical application of the new legislation in Baden Württemberg.
respiration, rehabilitation, weaning
Respiration20260
Catamenial Pneumothorax as an Underrecognized Manifestation of Thoracic Endometriosis: A 25-Year Single-Center Experience.
endometriosis, thoracic surgery, lung, diaphragm, lung diseases, pneumothorax
J Clin Med20261

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1

By status:

Completed 1
Recruiting 1
Unknown 1

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Safety and clinical parameter assessment of self infusion therapy with Prolastin in patients with severe AATD
2024-515894-80-00 — safety, alpha 1-antitrypsin deficiency, therapeutics, alpha 1-antitrypsin, sunlight
Phase 3Recruiting2025

LeadR Networks

Main global connection map